Bone marrow mesenchymal stem cell therapy for voiding dysfunction - Abstract

Lower urinary tract symptoms can significantly impact quality of life.

Current standard treatments are not always effective and are associated with complications and side effects. The discovery of stem cells led to research into cell-based therapies for treatment of disorders of voiding dysfunction. Bone marrow mesenchymal stem cells are particularly promising given their ability to differentiate into a variety of cell types. Recent studies have investigated bone marrow stem cells to treat a number of functional voiding pathologies including bladder outlet obstruction, neurogenic bladder, and stress urinary incontinence. Experiments in tissue regeneration have also attempted to create artificial bladders and urethras. The purpose of this article is to critically review the literature regarding the use of bone marrow mesenchymal stem cells in treatment of voiding dysfunction.

Written by:
Yu A, Campeau L.   Are you the author?
Division of Urology, Department of Surgery, Jewish General Hospital, McGill University, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada.

Reference: Curr Urol Rep. 2015 Jul;16(7):516.
doi: 10.1007/s11934-015-0516-8


PubMed Abstract
PMID: 26025492

UroToday.com Stress Urinary Incontinence Section